Filing Details
Cingulate Inc. (NASDAQ:CING) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CING
Cingulate Inc. (CING) Files Quarterly Report for Q0
Cingulate Inc. (NASDAQ:CING) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
Cingulate Inc. (NASDAQ:CING) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Cingulate Inc. (NASDAQ: CING) filed its quarterly report (Form 10-Q) with the SEC on August 13, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $4.99 with a market capitalization of $23.4 million.
- The article does not disclose Q0 revenue figures or other specific financial metrics from the quarterly report.
Market Context
Cingulate Inc.'s stock currently trades at $4.99 with a market capitalization of $23.4M.
The 10-Q provides Cingulate Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Cingulate Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CING Stock Page
Frequently Asked Questions
Where can I read CING's SEC filings?
Browse all filings on our CING SEC filings page.
What types of SEC filings does Cingulate Inc. file?
Public companies like Cingulate Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.